Product Information

DOXEPIN 10 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.0796 per EA under NDC 62135056090. Its NADAC has been published 193 times since Mar 8, 2023.

FDA first approved this application on Sep 4, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXEPIN 10 MG CAPSULE

Doxepin Hydrochloride
$0.0796per EA

Strength

10 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135056090

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210268

FDA Approved

9/4/2020

TE Code

AB

On Market Since

9/4/2020

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN 10 MG CAPSULE has been published 193 times since Mar 8, 2023, and over the history we have for it it has declined 41.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0796 per EA
All-time high$0.1473 (Sep 13, 2023)
All-time low$0.0625 (Nov 20, 2024)
52-week high$0.0812
52-week low$0.0776
Median price$0.0906
Average price$0.0953
Largest weekly change+47.8% (Jun 19, 2024)
Weeks tracked193
Tracking sinceMar 8, 2023

Price History

1W

0.0%

1M

+2.3%

3M

+2.5%

6M

-1.9%

1Y

-0.8%

3Y

-21.4%

5Y

N/A

All

-41.6%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXEPIN 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 10 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.0796 per EA (NDC 62135056090), effective Nov 11, 2026.

How has the price of DOXEPIN 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOXEPIN 10 MG CAPSULE has declined 41.6%. It has been tracked across 193 weekly CMS publications since Mar 8, 2023.

What are the highest and lowest recorded NADAC prices for DOXEPIN 10 MG CAPSULE?

Since Mar 8, 2023, the NADAC for DOXEPIN 10 MG CAPSULE has ranged from a low of $0.0625 (Nov 20, 2024) to a high of $0.1473 (Sep 13, 2023), with a median of $0.0906 per EA.

Are there cheaper alternatives to DOXEPIN 10 MG CAPSULE?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN 10 MG CAPSULE, is $0.0776 per EA — about 3% below DOXEPIN 10 MG CAPSULE.

Who manufactures DOXEPIN 10 MG CAPSULE?

DOXEPIN 10 MG CAPSULE (NDC 62135056090) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.